Chronic nitric oxide synthase inhibition prevents new coronary capillary generation

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 3, 2004, Pages 322-328

  Girardot, Daphné ^a   Jover, Bernard ^b   Moles, Jean Pierre ^b   DeBlois, Denis ^a,c   Moreau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIV MONTPELLIER   (France)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiogenesis; Capillary density; Cardiac remodeling; Hypertension; Nitric oxide

Indexed keywords

COLLAGEN TYPE 1; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY ARTERY; ENZYME INHIBITION; ENZYME SYNTHESIS; HEART AFTERLOAD; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; HYPOTHESIS; IN VITRO STUDY; INCUBATION TIME; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; AORTA; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CAPILLARIES; CARDIAC VOLUME; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY VESSELS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEART; HEART VENTRICLES; MALE; NEOVASCULARIZATION, PATHOLOGIC; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; ORGAN SIZE; PENICILLAMINE; RATS; RATS, WISTAR; VENTRICULAR REMODELING;

EID: 4344604422     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000134819.00517.e0     Document Type: Article

References (33)

1. Bugra Z, Koylan N, Vural A, et al. Left ventricular geometric patterns and QT dispersion in untreated essential hypertension. Am J Hypertens. 1998; 11:1164-1170.
2. Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
3. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci. USA. 1989; 86:3375-3378.
4. Ribeiro MO, Antunes E, de Nucci G, et al. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension. 1992;20:298-303.
5. Matsubara BB, Matsubara LS, Zornoff LA, et al. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats. Basic Res Cardiol. 1998;93:173-181.
6. Bartunek J, Weinberg EO, Tajima M, et al. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension: novel molecular adaptation to systolic load in absence of hypertrophy. Circulation. 2000;101:423-429.
7. Folkman J. Angiogenesis: initiation and control. Ann N Y Acad Sci. 1982; 401:212-227.
8. Plyley MJ, Olmstead BJ, Noble EG. Time course of changes in capillarization in hypertrophied rat plantaris muscle. J Appl Physiol. 1998;84: 902-907.
9. Granger HJ, Ziche M, Hawker JR Jr, et al. Molecular and cellular basis of myocardial angiogenesis. Cell Mol Biol Res. 1994;40:81-85.
10. Conway EM, Collen D, Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001;49:507-521.
11. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101: 2567-2578.
12. Noiri E, Lee E, Testa J, et al. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol. 1998;274:C236-C244.
13. Nicosia RF, Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol. 1990;26:119-128.
14. , Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol. 1972;54:626-637.
15. Montesano R, Orci L, Vassalli P. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol. 1983;97:1648-1652.
16. Der Sarkissian S, Marchand EL, Duguay D, et al. Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril. Cardiovasc Res. 2003;57:775-783.
17. Ziche M, Morbidelli L. Nitric oxide and angiogenesis. J Neurooncol. 2000;50:139-148.
18. Papapetropoulos A, Desai KM, Rudic RD, et al. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol. 1997;150:1835-1844.
19. Babaei S, Teichert-Kuliszewska K, Monge JC, et al. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res. 1998;82:1007-1015.
20. Babaei S, Stewart DJ. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovasc Res. 2002;55:190-200.
21. Pereira LM, Mandarim-De-Lacerda CA. Quantitative study of myocardial microcirculation in arterial hypertension due to progressive inhibition of NO synthesis. Arq Bras Cardiol. 1999;73:407-418.
22. Sladek T, Gerova M, Znojil V, et al. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res. 1996;45:335-338.
23. Takemoto M, Egashira K, Usui M, et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis ofcoronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest. 1997;99:278-287.
24. Arnal JF, el Amrani AI, Chatellier G, et al. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 1993;22:380-387.
25. Moreau P, Takase H, d'Uscio LV, et al. Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery. Stroke. 1998;29:1031-1035; discussion 1035-1036.
26. Tomanek RJ, Torry RJ. Growth of the coronary vasculature in hypertrophy: mechanisms and model dependence. Cell Mol Biol Res. 1994;40: 129-136.
27. Bishop SP, Powell PC, Hasebe N, et al. Coronary vascular morphology in pressure-overload left ventricular hypertrophy. J Mol Cell Cardiol. 1996; 28:141-154.
28. Anversa P, Capasso JM. Loss of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats. Am J Physiol. 1991;260:H1552-H1560.
29. Rakusan K, Flanagan MF, Geva T, et al. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation. 1992;86:38-46.
30. Kubis N, Besnard S, Silvestre JS, et al. Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme. J Hypertens. 2002;20:273-280.
31. Leuwerke SM, Kaza AK, Tribble CG, et al. Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol. 2002;282:L1272-L1278.
32. Li JS, Sventek P, Schiffrin EL. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 1996;14: 1331-1339.
33. Miyamoto T, Takeishi Y, Shishido T, et al. Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arteriovenous shunt in rabbits. Jpn Heart J. 2003;44:127-137.